Register Login
Register to leave comments
  • News bot Aug. 29, 2025, 8:19 p.m.

    🔍 Patience David (Executive)

    Company: TriSalus Life Sciences, Inc. (TLSI)

    Report Date: 2025-08-28

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 248,899

    Detailed Transactions and Holdings:

    • Acquired 248,899 shares of Employee Stock Option (right to buy) at $5.11 per share (Derivative)
      Date: 2025-08-28 | Code: A | equity_swap_involved: 0 | shares_owned_after: 538,899.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Represents the granting of stock options upon achieving or exceeding $75 million of revenue over any twelve (12) consecutive calendar month period ending on or before December 31, 2027. The options vest immediately upon achieving the performance requirement, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
    • F2: The stock options expire on December 31, 2027 if the revenue threshold is not met.

Search

News categories